$NTRA
Natera, Inc.

2020 Q4 Form 10-Q Financial Statement

#000155837020012997 Filed on November 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $112.4M $98.14M $77.91M
YoY Change 35.03% 25.97% 19.35%
Cost Of Revenue $59.90M $51.80M $43.90M
YoY Change 34.61% 18.0% 5.28%
Gross Profit $52.50M $46.30M $34.03M
YoY Change 35.39% 36.06% 44.18%
Gross Profit Margin 46.71% 47.18% 43.68%
Selling, General & Admin $94.10M $75.68M $56.72M
YoY Change 60.58% 33.44% 47.7%
% of Gross Profit 179.24% 163.45% 166.67%
Research & Development $32.40M $26.42M $12.80M
YoY Change 116.0% 106.48% 3.19%
% of Gross Profit 61.71% 57.06% 37.6%
Depreciation & Amortization $2.390M $2.180M $5.921M
YoY Change 32.04% -63.18% 213.28%
% of Gross Profit 4.55% 4.71% 17.4%
Operating Expenses $126.4M $102.1M $69.51M
YoY Change 71.74% 46.88% 37.1%
Operating Profit -$73.90M -$55.78M -$21.09M
YoY Change 112.22% 164.42% -22.16%
Interest Expense -$4.300M $4.270M $2.672M
YoY Change 65.38% 59.81% -195.43%
% of Operating Profit
Other Income/Expense, Net $1.900M $1.700M $700.0K
YoY Change -13.64% 142.86% 75.0%
Pretax Income -$76.40M -$58.30M -$23.09M
YoY Change 117.05% 152.45% -21.72%
Income Tax $0.00 $25.00K $44.00K
% Of Pretax Income
Net Earnings -$76.40M -$58.32M -$23.14M
YoY Change 117.15% 152.08% -21.88%
Net Earnings / Revenue -67.97% -59.43% -29.7%
Basic Earnings Per Share -$0.33
Diluted Earnings Per Share -$890.4K -$720.6K -$0.33
COMMON SHARES
Basic Shares Outstanding 85.37M 79.89M 70.46M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $737.3M $809.6M $238.3M
YoY Change 67.19% 239.74% 44.07%
Cash & Equivalents $48.67M $209.4M $51.66M
Short-Term Investments $688.6M $600.2M $186.7M
Other Short-Term Assets $26.80M $15.40M $14.10M
YoY Change 62.42% 9.22% 33.02%
Inventory $20.03M $20.38M $12.50M
Prepaid Expenses
Receivables $78.57M $70.67M $58.90M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $862.7M $916.0M $323.7M
YoY Change 64.89% 182.98% 30.16%
LONG-TERM ASSETS
Property, Plant & Equipment $33.35M $28.25M $43.80M
YoY Change 43.23% -35.5% 76.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.74M $12.16M $12.70M
YoY Change 18.17% -4.28% 234.21%
Total Long-Term Assets $69.49M $60.70M $56.60M
YoY Change 16.81% 7.25% 97.9%
TOTAL ASSETS
Total Short-Term Assets $862.7M $916.0M $323.7M
Total Long-Term Assets $69.49M $60.70M $56.60M
Total Assets $932.2M $976.7M $380.3M
YoY Change 59.98% 156.83% 37.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.096M $9.250M $9.200M
YoY Change -5.9% 0.54% -7.07%
Accrued Expenses $60.41M $62.89M $44.20M
YoY Change 23.17% 42.29% 36.84%
Deferred Revenue $50.13M $51.23M
YoY Change -10.52%
Short-Term Debt $50.05M $50.10M $50.10M
YoY Change -0.14% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $199.1M $195.9M $138.0M
YoY Change 10.66% 41.94% 35.56%
LONG-TERM LIABILITIES
Long-Term Debt $202.5M $200.0M $73.60M
YoY Change 174.76% 171.74% 0.41%
Other Long-Term Liabilities $320.0K $310.0K $84.00M
YoY Change 3.23% -99.63% 84.21%
Total Long-Term Liabilities $320.0K $310.0K $157.6M
YoY Change 3.23% -99.8% 32.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $199.1M $195.9M $138.0M
Total Long-Term Liabilities $320.0K $310.0K $157.6M
Total Liabilities $445.9M $440.7M $295.6M
YoY Change 46.71% 49.09% 33.94%
SHAREHOLDERS EQUITY
Retained Earnings -$929.3M -$852.9M
YoY Change 32.92%
Common Stock $1.411B $1.384B
YoY Change 44.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $486.2M $536.0M $84.69M
YoY Change
Total Liabilities & Shareholders Equity $932.2M $976.7M $380.3M
YoY Change 59.98% 156.83% 37.14%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$76.40M -$58.32M -$23.14M
YoY Change 117.15% 152.08% -21.88%
Depreciation, Depletion And Amortization $2.390M $2.180M $5.921M
YoY Change 32.04% -63.18% 213.28%
Cash From Operating Activities -$73.30M -$33.13M -$48.39M
YoY Change 387.04% -31.54% 107.95%
INVESTING ACTIVITIES
Capital Expenditures -$7.530M -$1.940M $2.554M
YoY Change 211.16% -175.96% -572.96%
Acquisitions
YoY Change
Other Investing Activities -$91.64M -$108.4M $30.85M
YoY Change -52.48% -451.38% -151.43%
Cash From Investing Activities -$99.16M -$110.4M -$71.11M
YoY Change -49.21% 55.19% 17.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $271.0M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.80M 275.6M 120.2M
YoY Change -94.65% 129.38% 14.82%
NET CHANGE
Cash From Operating Activities -73.30M -33.13M -48.39M
Cash From Investing Activities -99.16M -110.4M -71.11M
Cash From Financing Activities 11.80M 275.6M 120.2M
Net Change In Cash -160.7M 132.1M 660.0K
YoY Change -1656.78% 19921.21% -96.83%
FREE CASH FLOW
Cash From Operating Activities -$73.30M -$33.13M -$48.39M
Capital Expenditures -$7.530M -$1.940M $2.554M
Free Cash Flow -$65.77M -$31.19M -$50.94M
YoY Change 420.74% -38.78% 124.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85281000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78005000
dei Entity Registrant Name
EntityRegistrantName
Natera, Inc.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0001604821
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Address Country
EntityAddressCountry
US
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
001-37478
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0894487
dei Entity Address Address Line1
EntityAddressAddressLine1
201 Industrial Road, Suite 410
dei Entity Address City Or Town
EntityAddressCityOrTown
San Carlos
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94070
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
249-9090
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
NTRA
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
85369897
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
209351000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61926000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
178000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
55000
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
600205000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
379065000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3080000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2919000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70674000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53351000
CY2020Q3 us-gaap Inventory Net
InventoryNet
20377000
CY2019Q4 us-gaap Inventory Net
InventoryNet
12394000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15227000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16376000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
916012000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
523167000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28249000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23283000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20296000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23730000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12156000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12476000
CY2020Q3 us-gaap Assets
Assets
976713000
CY2019Q4 us-gaap Assets
Assets
582656000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9250000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8604000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22450000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16088000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
62893000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49043000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
51227000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
56016000
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
50052000
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
50123000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
195872000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
179874000
CY2020Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
199959000
CY2019Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
73656000
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23128000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23808000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21444000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26297000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
310000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
310000
CY2020Q3 us-gaap Liabilities
Liabilities
440713000
CY2019Q4 us-gaap Liabilities
Liabilities
303945000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85281000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78005000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
9000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1383727000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
976955000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-852906000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-699171000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5170000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
919000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
536000000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
278711000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
976713000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
582656000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98143000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77909000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
278627000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
219088000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26421000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12796000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
67651000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36355000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75678000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56715000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
209547000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
147589000
CY2019Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
14388000
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
14388000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
153920000
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
99003000
us-gaap Costs And Expenses
CostsAndExpenses
420936000
us-gaap Costs And Expenses
CostsAndExpenses
300564000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-55777000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21094000
us-gaap Operating Income Loss
OperatingIncomeLoss
-142309000
us-gaap Operating Income Loss
OperatingIncomeLoss
-81476000
CY2020Q3 us-gaap Interest Expense
InterestExpense
4270000
CY2019Q3 us-gaap Interest Expense
InterestExpense
2672000
us-gaap Interest Expense
InterestExpense
10772000
us-gaap Interest Expense
InterestExpense
8117000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1749000
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
673000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5661000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1962000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58298000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23093000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-153268000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-87631000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2013000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-58323000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-23137000
us-gaap Net Income Loss
NetIncomeLoss
-153331000
us-gaap Net Income Loss
NetIncomeLoss
-89644000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-600000
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
63000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4251000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1410000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58923000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23074000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-149080000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-88234000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.93
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.33
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80908000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70456000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79430000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67198000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
93088000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4433000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10247000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
63000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-23137000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
84694000
us-gaap Net Income Loss
NetIncomeLoss
-153331000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
536000000
us-gaap Profit Loss
ProfitLoss
-153331000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-89644000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6215000
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5921000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
32162000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10416000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2147000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
107595000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
506000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20102000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1410000
us-gaap Net Income Loss
NetIncomeLoss
-89644000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
84694000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
304267000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4974000
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
270650000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15032000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-600000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-58323000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
536000000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
278711000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15782000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3062000
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
82873000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
270650000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34406000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4251000
ntra Cumulative Effect Of New Accounting Principle In Period Of Adoption Duration
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionDuration
-404000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
3333000
CY2019Q3 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
400000
us-gaap Share Based Compensation
ShareBasedCompensation
34406000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
20102000
us-gaap Operating Lease Cost
OperatingLeaseCost
5819000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
5807000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
149000
CY2019Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
336000
us-gaap Inventory Write Down
InventoryWriteDown
-180000
CY2019Q3 us-gaap Inventory Write Down
InventoryWriteDown
719000
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1310000
CY2019Q3 ntra Right Of Use Asset Impairment Charges
RightOfUseAssetImpairmentCharges
361000
CY2019Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
497000
us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
135000
CY2019Q3 us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
22000
CY2019Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
14388000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1445000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
ntra Accretion Of Convertible Notes Interest Expense Debt
AccretionOfConvertibleNotesInterestExpenseDebt
4514000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
3062000
CY2019Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2147000
CY2019Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10416000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17940000
CY2019Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2491000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7803000
CY2019Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-400000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7288000
CY2019Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9321000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-97000
CY2019Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9299000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1613000
CY2019Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5194000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6362000
CY2019Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1569000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
16362000
CY2019Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1683000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5470000
CY2019Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
42864000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-109210000
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48390000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
479037000
CY2019Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
197009000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
11500000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
247315000
CY2019Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
118780000
CY2019Q3 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
9675000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12073000
CY2019Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2554000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-232295000
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-71108000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15782000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
278316000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
78757000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
270650000
CY2019Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
107595000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
489053000
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120158000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
147548000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
660000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61981000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51004000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209529000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51664000
us-gaap Interest Paid Net
InterestPaidNet
3137000
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
9894000
CY2019Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
28191000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2814000
CY2019Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
56000
us-gaap Net Income Loss
NetIncomeLoss
-153300000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-852900000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209500000
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
600200000
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
50100000
CY2019Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
600000
CY2019Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
108100000
CY2019Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
400000
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
216200000
CY2020Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
300000
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
271000000.0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:40.3pt;margin:0pt;">The preparation of financial statements in accordance with generally accepted accounting principles (GAAP) in the United States requires management to make estimates and assumptions about future events that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Significant items subject to such estimates include the allowance for doubtful accounts calculated based on the average selling price expected to be received from insurance payors, the operating right-of-use assets and the associated lease liabilities, deferred revenues associated with unsatisfied performance obligations, accrued liability for potential refund requests, the valuation of the Convertible Notes, stock-based compensation, the fair value of common stock, income tax uncertainties, and the expected consideration to be received from contracts with customers. These estimates and assumptions are based on management's best estimates and judgment. Management regularly evaluates its estimates and </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">assumptions using historical experience and other factors, including contractual terms and statutory limits; however, actual results could differ from these estimates and could have an adverse effect on the Company's financial statements.</p>
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2919000
CY2020Q3 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
404000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1445000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
457000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4311000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;margin:10pt 0pt 0pt 0pt;"><span style="font-style:italic;font-weight:bold;">Risk and Uncertainties</span></p><p style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict, and the full extent and duration of the impact of the COVID 19 pandemic on our business, our operations, and the global economy as a whole is not yet known. While the Company’s test volumes as well as overall average selling prices increased in Q3 2020 compared to Q2 2020, the Company cannot predict the potential nature, magnitude and duration of the effects of the COVID-19 pandemic on the macroeconomic environment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to credit risk consist of cash, accounts receivable and investments. The Company limits its exposure to credit loss by placing its cash in financial institutions with high credit ratings. The Company's cash may consist of deposits held with banks that may at times exceed federally insured limits. The Company performs evaluations of the relative credit standing of these financial institutions and limits the amount of credit exposure with any one institution. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt;">The Company performs evaluations of financial conditions for insurance carriers, patients, clinics and laboratory partners and generally does not require collateral to support credit sales. For the three and nine months ended September </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">30, 2020, and 2019, there were no customers exceeding 10% of total revenues on an individual basis. As of September 30, 2020 and December 31, 2019, there were no customers with an outstanding balance exceeding 10% of net accounts receivable. </p>
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5770000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
795000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
919000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-552000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5170000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
858000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5170000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
858000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98143000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77909000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
278627000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
219088000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98143000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77909000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
278627000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
219088000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70674000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53351000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
51227000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
56016000
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23128000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23808000
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
74355000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
79824000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
79824000
ntra Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1579000
ntra Contract With Customer Liability Noncurrent Reclassification To Current
ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent
-801000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-5290000
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
-957000
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
74355000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-5300000
ntra Number Of Investments Sold
NumberOfInvestmentsSold
11500000
CY2020Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
8
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
338583000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
339655000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
256464000
us-gaap Depreciation
Depreciation
6200000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
260550000
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47667000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41524000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28249000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23283000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
595047000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
600205000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
75916000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
64807000
CY2020Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2153000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
1850000
CY2020Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7376000
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
5767000
CY2020Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
6964000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
5710000
CY2020Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
5957000
CY2019Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
2761000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22450000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16088000
CY2020Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
13322000
CY2019Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
9410000
CY2020Q3 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
5668000
CY2019Q4 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
8408000
CY2020Q3 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
8618000
CY2019Q4 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
4301000
CY2020Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3235000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2957000
CY2020Q3 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
4666000
CY2019Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
2873000
CY2020Q3 ntra Accrued Shipping Charges
AccruedShippingCharges
745000
CY2019Q4 ntra Accrued Shipping Charges
AccruedShippingCharges
305000
CY2020Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1405000
CY2019Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1691000
CY2020Q3 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
2247000
CY2019Q4 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
2269000
CY2020Q3 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
1828000
CY2019Q4 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
1092000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6380000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5739000
CY2020Q3 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
1959000
CY2019Q4 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
1482000
CY2020Q3 ntra Accrued Interest
AccruedInterest
2965000
CY2020Q3 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
9855000
CY2019Q4 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
8516000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
62893000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49043000
CY2019Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
9410000
CY2018Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
10012000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
11912000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
7193000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
8000000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
8513000
CY2020Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
13322000
CY2019Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
8692000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2756000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1895000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6380000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21444000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
27824000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M25D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1077
CY2020Q3 us-gaap Lease Cost
LeaseCost
1900000
us-gaap Lease Cost
LeaseCost
5800000
CY2019Q3 us-gaap Lease Cost
LeaseCost
2000000.0
us-gaap Lease Cost
LeaseCost
5800000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2200000
us-gaap Operating Lease Payments
OperatingLeasePayments
6600000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2244000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9067000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9319000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7797000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2400000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4730000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
35557000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7733000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
27824000
CY2020Q3 us-gaap Purchase Obligation
PurchaseObligation
40326000
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
25000
us-gaap Repayments Of Debt
RepaymentsOfDebt
79200000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
75000000.0
CY2020Q3 ntra Debt Early Payment Penalties
DebtEarlyPaymentPenalties
3800000
us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
400000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
75000000
CY2020Q3 ntra Debt Early Payment Penalties
DebtEarlyPaymentPenalties
3757000
CY2020Q3 ntra Reacquisition Of Debt Amount
ReacquisitionOfDebtAmount
78757000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
75000000
CY2020Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2091000
CY2020Q3 ntra Extinguishment Of Debt Carrying Amount
ExtinguishmentOfDebtCarryingAmount
72909000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000.0
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2020Q3 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9700000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8600000
CY2020Q3 ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-58323000
CY2019Q3 ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-23137000
ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-153331000
ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-89644000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80908000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70456000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79430000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67198000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.93
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.33
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18699000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11191000

Files In Submission

Name View Source Status
0001558370-20-012997-index-headers.html Edgar Link pending
0001558370-20-012997-index.html Edgar Link pending
0001558370-20-012997.txt Edgar Link pending
0001558370-20-012997-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ntra-20200930.xsd Edgar Link pending
ntra-20200930x10q.htm Edgar Link pending
ntra-20200930x10q_htm.xml Edgar Link completed
ntra-20200930xex31d1.htm Edgar Link pending
ntra-20200930xex31d2.htm Edgar Link pending
ntra-20200930xex32d1.htm Edgar Link pending
ntra-20200930xex32d2.htm Edgar Link pending
ntra-20200930_cal.xml Edgar Link unprocessable
ntra-20200930_def.xml Edgar Link unprocessable
ntra-20200930_lab.xml Edgar Link unprocessable
ntra-20200930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending